Stay updated with the latest eyelid news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on eyelid topics.
Lupin announced the completion of its acquisition of VISUfarma B.V. (VISUfarma), a leading European specialty pharmaceutical company focused on ophthalmology, from GHO Capital Partners LLP (GHO). The acquisition represents a significant milestone in Lupin's strategy to expand its specialty care portfolio and strengthen its presence in Europe. The integration of VISUfarma has significantly expanded Lupin's ophthalmology portfolio to over 60 branded products spanning dry eye, glaucoma, eyelid hyg ...Read More >
New Delhi [India], April 2 (ANI): Lupin Ltd. has completed the acquisition of VISUfarma B.V, a European pharmaceutical company focused on ophthalmology, the company said in an exchange filing on Thursday. Lupin said the acquisition is a "significant milestone" in its strategy to expand the speciality care portfolio and strengthen its presence in the European region. "The integration of VISUfarma has significantly expanded Lupin's ophthalmology portfolio to over 60 branded products spanning dry ...Read More >
Bengaluru: As many as 186 firecracker-related eye injuries, including 103 involving children, were reported between Sunday and Wednesday in the city.Hospitals across Bengaluru treated patients for corneal abrasions and tears, conjunctival congestions, tears in the eyelids, singed eyelashes, and soot particles embedded in the eye. While most of the injuries were mild and superficial, a few required surgical intervention.At Minto Hospital, 44 injuries (21 children and 23 adults) were reported acro ...Read More >
New Delhi, Sep 29 (PTI) Drug maker Lupin on Monday said its subsidiary has inked a pact to fully acquire Amsterdam-headquartered VISUfarma BV at an enterprise value of 190 million euros. The company's wholly-owned subsidiary, Nanomi BV has signed a definitive agreement for the acquisition of VISUfarma BV, a portfolio company of global healthcare specialist investor GHO Capital Partners LLP, the Mumbai-based drug maker said in a statement. The acquisition of VISUfarma, with its broad portfolio ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.